富士製薬工業(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4554/E00975-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2022/03/18日証協無担保0株0.00%0株0.00%1,528株-96.49%
2022/03/18日証協有担保22,500株+52.03%2,400株-70.73%47,800株+602.94%
2022/03/11日証協無担保0株0.00%0株0.00%43,520株+35.10%
2022/03/11日証協有担保14,800株-5.73%8,200株+583.33%6,800株-32.67%
2022/03/04日証協無担保0株0.00%0株0.00%32,212株+2584.33%
2022/03/04日証協有担保15,700株-18.65%1,200株0.00%10,100株-50.73%
2022/02/25日証協無担保0株0.00%0株0.00%1,200株+20.00%
2022/02/25日証協有担保19,300株+156.00%0株0.00%20,500株-25.38%
2022/02/18日証協無担保0株0.00%0株0.00%1,000株+42.86%
2022/02/18日証協有担保7,539株-57.81%0株-100.00%27,473株+9.48%
2022/02/10日証協無担保0株0.00%0株0.00%700株-76.67%
2022/02/10日証協有担保17,868株+19.37%5,400株+350.00%25,094株-23.96%
2022/02/04日証協無担保0株-100.00%0株0.00%3,000株+114.29%
2022/02/04日証協有担保14,968株-11.49%1,200株+300.00%33,000株+6.75%
2022/01/28日証協無担保1,400株+55.56%0株-100.00%1,400株-64.12%
2022/01/28日証協有担保16,912株-46.57%300株0.00%30,912株-17.57%
2022/01/21日証協無担保900株0.00%14,292株0.00%3,902株+50.08%
2022/01/21日証協有担保31,650株+99.06%300株-88.46%37,500株+321.35%
2022/01/14日証協無担保0株0.00%0株0.00%2,600株+3.96%
2022/01/14日証協有担保15,900株+504.33%2,600株-60.00%8,900株+38.91%
2022/01/07日証協無担保0株-100.00%0株0.00%2,501株-62.68%
2022/01/07日証協有担保2,631株-30.76%6,500株+408.61%6,407株+100.22%
2021/12/30日証協無担保500株0.00%0株0.00%6,701株0.00%
2021/12/30日証協有担保3,800株0.00%1,278株0.00%3,200株0.00%
2021/12/24日証協無担保500株0.00%0株0.00%6,701株+36.76%
2021/12/24日証協有担保3,800株-91.34%1,278株0.00%3,200株-88.61%
2021/12/17日証協無担保0株-100.00%0株0.00%4,900株+81.48%
2021/12/17日証協有担保43,900株+230.50%0株-100.00%28,095株-24.60%
2021/12/10日証協無担保500株-72.22%0株0.00%2,700株+22.73%
2021/12/10日証協有担保13,283株-82.15%3,400株-93.96%37,263株+8.09%
2021/12/03日証協無担保1,800株0.00%0株0.00%2,200株+214.29%
2021/12/03日証協有担保74,400株+118.18%56,270株+9999.99%34,475株+117.22%
2021/11/26日証協無担保0株-100.00%0株0.00%700株-75.86%
2021/11/26日証協有担保34,100株+40.91%100株0.00%15,871株+15.17%
2021/11/19日証協無担保600株+50.00%0株0.00%2,900株+222.22%
2021/11/19日証協有担保24,200株-50.91%0株-100.00%13,780株-30.40%
2021/11/05日証協無担保300株0.00%0株0.00%900株-35.71%
2021/11/05日証協有担保40,900株+56.70%2,400株+2300.00%19,100株+50.39%

※株式分割は考慮していませんのでご注意ください。

Page Top